Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
| ▸ | ADH1B | P00325 | 1/20 | 0.46 |
| ▸ | ADH1C | P00326 | 1/20 | 0.46 |
| ▸ | ADH1A | P07327 | 1/20 | 0.46 |
| ▸ | ADH4 | P08319 | 1/20 | 0.46 |
| ▸ | ADH7 | P40394 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.44 |
| ▸ | SAT1 | P21673 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22210655 | 1.00 | CYP2D6 (0.47) | CYP2D6SIGMAR1ADH1BADH1CADH1A | |
| SCHEMBL22452409 | 1.00 | CYP2D6 (0.47) | CYP2D6SIGMAR1ADH1BADH1CADH1A | |
| SCHEMBL6963827 | 0.98 | SAT1 (0.45) | CYP2D6SIGMAR1ADH1BADH1CADH1A | |
| SCHEMBL22210659 | 0.96 | CA12 (0.48) | CYP2D6SIGMAR1ADH1BADH1CADH1A | |
| SCHEMBL22210658 | 0.96 | CA12 (0.48) | CYP2D6SIGMAR1ADH1BADH1CADH1A | |
| SCHEMBL22863919 | 0.94 | SAT1 (0.53) | CYP2D6SIGMAR1ADH1BADH1CADH1A | |
| SCHEMBL4527928 | 0.93 | — | — | |
| SCHEMBL10936950 | 0.91 | SIGMAR1 (0.48) | CYP2D6SIGMAR1ADH1BADH1CADH1A | |
| SCHEMBL6974114 | 0.91 | SIGMAR1 (0.48) | CYP2D6SIGMAR1ADH1BADH1CADH1A | |
| SCHEMBL6970039 | 0.89 | SIGMAR1 (0.52) | CYP2D6SIGMAR1ADH1BADH1CADH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240092964-A1 | IMPREGNATION RESIN FOR A WOVEN OR STITCHED FABRIC | SIKA TECHNOLOGY AG (CH) | 2024-03-21 | — | — | US | claimed |
| EP-4051724-A1 | IMPREGNATION RESIN FOR A WOVEN OR STITCHED FABRIC | Sika Technology AG (CH) | 2022-09-07 | — | — | EP | claimed |
| CN-114651096-A | Impregnating resins for woven or stitched fabrics | SIKA技术股份公司 | 2022-06-21 | — | — | CN | claimed |
| WO-2021083744-A1 | IMPREGNATION RESIN FOR A WOVEN OR STITCHED FABRIC | SIKA TECHNOLOGY AG (CH) | 2021-05-06 | — | — | WO | claimed |
| US-12528905-B2 | Amine-epoxy resin addition product | SIKA TECHNOLOGY AG (CH) | 2026-01-20 | — | — | US | disclosed |
| US-12516148-B2 | Amine epoxy resin adduct | SIKA TECHNOLOGY AG (CH) | 2026-01-06 | — | — | US | disclosed |
| EP-4370580-B1 | HARDENER FOR EPOXIDE RESINS | SIKA TECH AG (CH) | 2025-04-30 | — | — | EP | disclosed |
| US-12275817-B2 | Hardener for epoxy resins | SIKA TECHNOLOGY AG (CH) | 2025-04-15 | — | — | US | disclosed |
| EP-4284853-B1 | ADDUCT OF ALKYLATED DIAMINE AND NOVOLAK EPOXY RESIN | SIKA TECH AG (CH) | 2025-03-19 | — | — | EP | disclosed |
| EP-4240799-B1 | SOIL PROTECTION SYSTEM WITH HIGH DYNAMIC CRACK BRIDGING | SIKA TECH AG (CH) | 2025-01-08 | — | — | EP | disclosed |
| US-12146024-B2 | Accelerator for curing epoxy resins comprising alkylated amines | SIKA TECHNOLOGY AG (CH) | 2024-11-19 | — | — | US | disclosed |
| EP-4110845-B1 | AMINE EPOXY RESIN ADDUCT | SIKA TECH AG (CH) | 2024-09-04 | — | — | EP | disclosed |
| EP-3144334-A1 | HARDENER FOR LOW-EMISSION EPOXY RESIN COMPOSITIONS | Sika Technology AG (CH) | 2017-03-22 | — | — | EP | disclosed |
| US-20150272900-A1 | Layer-By-Layer Approach to Co-Deliver DNA and siRNA via AuNPs: A Potential Platform for Modifying Release Kinetics | THE JOHNS HOPKINS UNIVERSITY | 2015-10-01 | — | — | US | disclosed |
| US-20140378356-A1 | CYLINDER LUBRICATING OIL COMPOSITION FOR CROSSHEAD DIESEL ENGINE | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2014-12-25 | — | — | US | disclosed |
| WO-2009067233-A1 | BETA CARBOLINES AND USES THEREOF | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2009-05-28 | — | — | WO | disclosed |
| EP-0870765-B1 | AMINOTHIAZOLE DERIVATIVES, DRUG CONTAINING THE SAME AND INTERMEDIATE IN THE PRODUCTION OF THE COMPOUNDS | ZERIA PHARM CO LTD (JP) | 2003-11-19 | — | — | EP | disclosed |
| US-6512000-B1 | Aminocarbonyl- substituted benzimidazole derivatives for the treatment of diseases in which inhibition of tryptase is of therapeutic such as for treating an inflammatory or allergic disease | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2003-01-28 | — | — | US | disclosed |
| US-5981557-A | HAVING IMPROVING EFFECTS ON THE DYSMOTILITY IN THE GASTROINTESTINAL TRACT | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1999-11-09 | — | — | US | disclosed |
| EP-0870765-A1 | AMINOTHIAZOLE DERIVATIVES, DRUG CONTAINING THE SAME AND INTERMEDIATE IN THE PRODUCTION OF THE COMPOUNDS | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150272900-A1 | Layer-By-Layer Approach to Co-Deliver DNA and siRNA via AuNPs: A Potential Platform for Modifying Release Kinetics | DNMT3L, DBNL, HNRNPL | CYP2D6 4034/4885SIGMAR1 2648/4885ADH1B 1840/4885 |
| US-12528905-B2 | Amine-epoxy resin addition product | RAD51, PTGER1, APEX1 | CYP2D6 1684/4885SIGMAR1 1074/4885ADH1B 3002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.